Tumors

System predicts tumor response to different treatments

Researchers recently discovered that two key proteins have opposite roles than what was previously believed

The discovery of an oncogene responsible for the deadliest brain tumor offers a promising new treatment target

Next-generation sequencing has revolutionized the detection of tumor neoantigens

Researchers develop a non-invasive tool to measure antibody penetration of tumors

A blood test to diagnose and classify tumors could be revolutionary and practice-changing for patients and clinicians alike

The new test is specifically designed to analyze and classify high-grade serous ovarian cancer, the most common and lethal form of ovarian cancer

New diagnostic test for MSI in solid tumors can inform physicians on immuno-oncology therapies, and can guide treatment decisions for patients with Lynch-associated cancers

Next-generation gene sequencing finds mutations in patients resistant to PSMA-targeting therapy

Researchers have identified important drivers that enable tumors to change their behavior and evade anticancer therapies